Question 1

What is BORTEZOMIB used for?

Accepted Answer

BORTEZOMIB (brand name Bortezomib) is a Other indicated for See full prescribing information.

Question 2

How does BORTEZOMIB work?

Accepted Answer

BORTEZOMIB works through the following mechanism: 12.1 Mechanism of Action Bortezomib is a reversible inhibitor of the chymotrypsin-like activity of the 26S proteasome in mammalian cells. The 26S proteasome is a large protein complex that degrades ubiquitinated proteins. The ubiquitin-proteasome pathway plays an essential role in regulating the intracellular concentration of specific proteins, thereby maintaining homeostasis within cells. Inhibition of the 26S proteasome prevents this targeted proteolysis, which can affect multiple signaling cascades within the cell. This disruption of normal homeostatic mechanisms can lead to cell death. Experiments have demonstrated that bortezomib is cytotoxic to a variety of cancer cell types in vitro . Bortezomib causes a delay in tumor growth in vivo in nonclinical tumor models, including multiple myeloma..

Question 3

What are the most common side effects of BORTEZOMIB?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for BORTEZOMIB. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is BORTEZOMIB the same as Bortezomib?

Accepted Answer

Bortezomib is a brand name for BORTEZOMIB. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

BORTEZOMIB

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations